Jula Inrig
Chief Medical Officer at Travere Therapeutics, Inc. (TVTX); Evp, Head Of R&D & Cmo at Travere Therapeutics, Inc. (TVTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 25,390119,775 held (−17%) | $62.02 | $1.6M | -16.0% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 17,284102,491 held (−14%) | $62.62 | $1.1M | -16.8% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 1,600100,891 held (−2%) | $63.69 | $102K | -18.2% |
| Sep 17SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 400100,491 held (−0%) | $65.31 | $26K | -20.2% |
| May 6SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 20,000111,473 held (−15%) | $45.00 | $900K | +15.8% |
| May 6SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 2,174113,549 held (−2%) | $46.65 | $101K | +11.7% |
| May 6SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 311113,238 held (−0%) | $43.95 | $14K | +18.6% |
| Apr 15SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 7,215112,491 held (−6%) | $41.93 | $303K | +24.3% |
| Apr 15SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 1,018111,473 held (−1%) | $42.61 | $43K | +22.3% |
| Feb 5SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 1,547105,938 held (−1%) | $32.11 | $50K | +62.3% |
| Feb 5SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 232105,706 held (−0%) | $32.85 | $8K | +58.7% |
| Feb 3SEC | TVTXTravere Therapeutics, Inc. | Sell | 6,956107,485 held (−6%) | $32.12 | $223K | +62.3% |
| Jan 7SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 2,03186,756 held (−2%) | $40.18 | $82K | +29.7% |
| Jan 7SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 44586,311 held (−1%) | $37.75 | $17K | +38.1% |
| Dec 29SEC | TVTXTravere Therapeutics, Inc. | Sell Plan | 15,00088,787 held (−14%) | $42.00 | $630K | +24.1% |
- Sell
Evp, Head Of R&D & Cmo Jula Inrig sold $1.6M of TVTX at $62.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of R&D & Cmo Jula Inrig sold $1.1M of TVTX at $62.62 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of R&D & Cmo Jula Inrig sold $102K of TVTX at $63.69 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of R&D & Cmo Jula Inrig sold $26K of TVTX at $65.31 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Jula Inrig sold $900K of TVTX at $45.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Jula Inrig sold $101K of TVTX at $46.65 — pre-scheduled 10b5-1 plan sale.